My research work is focused on a marker of tumor blood vessels, the Follicle Stimulating Hormone Receptor (FSHR), which is present in all major tumor types that we investigated, while having a very limited presence in normal tissues and organs.
We are evaluating the feasibility of FSHR blood tests, to detect the presence of tumors and to monitor their response to therapies based on FSHR released in blood. We are also working to elucidate the role of FSHR in cancer progression. Another area of investigation is the use of FSHR as a target for directing imaging and therapeutic agents into tumors.
